161 related articles for article (PubMed ID: 36697209)
1. Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis.
Papadopoulou E; Hansel J; Lazar Z; Kostikas K; Tryfon S; Vestbo J; Mathioudakis AG
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36697209
[TBL] [Abstract][Full Text] [Related]
2. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Sathananthan K; Fortescue R
Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
[TBL] [Abstract][Full Text] [Related]
3. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract][Full Text] [Related]
4. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Chong J; Cates CJ
Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
[TBL] [Abstract][Full Text] [Related]
5. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
[TBL] [Abstract][Full Text] [Related]
6. Digital interventions for the management of chronic obstructive pulmonary disease.
Janjua S; Banchoff E; Threapleton CJ; Prigmore S; Fletcher J; Disler RT
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013246. PubMed ID: 33871065
[TBL] [Abstract][Full Text] [Related]
7. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
Janjua S; Fortescue R; Poole P
Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
[TBL] [Abstract][Full Text] [Related]
9. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors for chronic obstructive pulmonary disease.
Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
[TBL] [Abstract][Full Text] [Related]
11. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Black PN; Cates CJ
Cochrane Database Syst Rev; 2012 Aug; (8):CD001287. PubMed ID: 22895919
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
14. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
15. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Frei A; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010257. PubMed ID: 30371937
[TBL] [Abstract][Full Text] [Related]
16. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
17. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
18. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.
Craig SS; Dalziel SR; Powell CV; Graudins A; Babl FE; Lunny C
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012977. PubMed ID: 32767571
[TBL] [Abstract][Full Text] [Related]
19. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Black PN
Cochrane Database Syst Rev; 2010 Feb; (2):CD001287. PubMed ID: 20166060
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
